Communicating DI Expectations to External Partners, CMOs and CROs
Communicating DI Expectations to External Partners, CMOs and CROs Effective Communication of Data Integrity Expectations to External Partners, CMOs, and CROs Maintaining data integrity within pharmaceutical development and manufacturing is non-negotiable throughout the product lifecycle. The US FDA, EMA, MHRA, and other regulatory agencies hold pharmaceutical companies accountable for ensuring that all GxP records generated…
Read More “Communicating DI Expectations to External Partners, CMOs and CROs” »